Abstract
Discovery of a series of pyrazolopiperidine sulfonamide based gamma-secretase inhibitors and its SAR evolution is described. Significant increases in APP potency on the pyrazolopiperidine scaffold over the original N-bicyclic sulfonamide scaffold were achieved and this potency increase translated in an improved in vivo efficacy.
2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Alzheimer Disease / drug therapy
-
Amyloid Precursor Protein Secretases / antagonists & inhibitors*
-
Amyloid Precursor Protein Secretases / metabolism*
-
Animals
-
Humans
-
Mice
-
Models, Molecular
-
Piperidines / chemistry*
-
Piperidines / pharmacology*
-
Piperidines / therapeutic use
-
Structure-Activity Relationship
-
Sulfonamides / chemistry*
-
Sulfonamides / pharmacology*
-
Sulfonamides / therapeutic use
Substances
-
Piperidines
-
Sulfonamides
-
Amyloid Precursor Protein Secretases